Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
cbdMD ( (YCBD) ) has provided an update.
On May 6, 2025, cbdMD executed significant changes to its stock structure. The company converted its 8% Series A Cumulative Convertible Preferred Stock into 65,000,000 shares of Common Stock, following shareholder approval on April 10, 2025. This conversion ceased dividend accruals and trading of the Preferred Stock on the NYSE American. Additionally, cbdMD implemented a one-for-8 reverse stock split of its Common Stock, effective immediately after the conversion, which also received shareholder approval. This split adjusted the CUSIP number and affected all shareholders uniformly, ensuring no fractional shares were issued.
Spark’s Take on YCBD Stock
According to Spark, TipRanks’ AI Analyst, YCBD is a Neutral.
cbdMD’s overall score reflects significant financial performance challenges with high leverage and negative cash flows. Despite a positive earnings call indicating a financial turnaround and achieving profitability, technical indicators suggest a bearish trend. Valuation remains a concern with negative P/E and no dividend. The company’s need to stabilize cash flows and manage liabilities is critical for future improvement.
To see Spark’s full report on YCBD stock, click here.
More about cbdMD
Average Trading Volume: 849,477
Technical Sentiment Signal: Sell
Current Market Cap: $801.6K
Find detailed analytics on YCBD stock on TipRanks’ Stock Analysis page.